256
P A R T 3
Drugs acting on the immune system
BIBLIOGRAPHY
Cavagna, L., Caporali, R., Trifiro, G., Arcoraci, V., Rossi, S. &
Montecucco, C. (2013). Overuse of prescription and OTC
non-steroidal anti-inflammatory drugs in patients with
rheumatoid arthritis and osteoarthritis.
International Journal of
Immunopathology & Pharmacology, 26,
279–281.
Corke, P. (2013). Postoperative pain management.
Australian
Prescriber, 36,
202–205.
D’Arcy, Y. (2011). Prescribing nonsteroidal anti-inflammatory drugs.
Nurse Practitioner, 36,
8–11.
Dempsey, J., Hillege, S. & Hill, R. (2014).
Fundamentals of
Nursing and Midwifery: A Person-centred Approach to Care
(2nd Australian and New Zealand edn). Sydney: Lippincott
Williams & Wilkins.
Firth, J. (2011). Rheumatoid arthritis: Treating to target with
disease-modifying drugs.
British Journal of Nursing, 20,
1240–1245.
Firth, J. & Critchley, S. (2011). Treating to target in rheumatoid
arthritis: Biologic therapies.
British Journal of Nursing, 20,
1284–1291.
Fitzgerald, G. A. (2004). Coxibs and cardiovascular disease.
New England Journal of Medicine, 351,
1709–1711.
Kennedy, D. (2011). Analgesics and pain relief in pregnancy and
breastfeeding.
Australian Prescriber, 34,
8–10.
Lu, T.Y-T. & Hill, C. (2006). Managing patients taking
tumour necrosis factor inhibitors.
Australian Prescriber,
29
, 67–70.
McKenna, L. (2012).
Pharmacology Made Incredibly Easy
(1st Australian and New Zealand edn). Sydney: Lippincott
Williams & Wilkins.
McKenna, L. & Mirkov, S. (2014).
McKenna’s Drug Handbook for
Nursing and Midwifery
(7th edn). Sydney: Lippincott Williams
& Wilkins.
O’Dell, J. R. (2004). Therapeutic strategies for rheumatoid arthritis.
New England Journal of Medicine, 350,
2591–2602.
Paul, S. P. & Whibley, J. (2010). Paracetamol prophylaxis: What the
evidence says.
Practice Nursing, 21,
530–532.
Porth, C. M. (2011).
Essentials of Pathophysiology: Concepts
of Altered Health States
(3rd edn). Philadelphia: Lippincott
Williams & Wilkins.
Porth, C. M. (2009).
Pathophysiology: Concepts of Altered Health
States
(8th edn). Philadelphia: Lippincott Williams & Wilkins.
Swaminathan, S. & Riminton, S. (2006). Monoclonal antibody
therapy for non-malignant disease.
Australian Prescriber, 29,
130–133.
Swanson, K. I. & Pfenning, S. (2011). The nurse practitioner’s role
in the management of rheumatoid arthritis.
Journal for Nurse
Practitioners, 7,
858–870.
Varghese, M. & Lockey, R. F. (2008). Aspirin-induced asthma.
Allergy, Asthma, and Clinical Immunology, 4(2)
, 75–83.
C H E C K Y O U R U N D E R S T A N D I N G
Answers to the questions in this chapter can be found in
Appendix A at the back of this book.
MULTIPLE CHOICE
Select the best answer to the following.
1.
A drug could be classified as an analgesic if it:
a.
reduces fever.
b.
reduces swelling.
c.
reduces redness.
d.
reduces pain.
2.
An antipyretic is a drug that can:
a.
block pain.
b.
block swelling.
c.
block fever.
d.
block inflammation.
3.
A nurse or midwife might not see a salicylate used as
an anti-inflammatory if a drug was needed for its:
a.
antipyretic properties.
b.
analgesic properties.
c.
OTC availability.
d.
parenteral availability.
4.
The NSAIDs affect the COX-1 and COX-2 enzymes.
By blocking COX-2 enzymes, the NSAIDs block
inflammation and the signs and symptoms of
inflammation at the site of injury or trauma. By
blocking COX-1 enzymes, these drugs block:
a.
fever regulation.
b.
prostaglandins that protect the stomach lining.
c.
swelling in the periphery.
d.
liver function.
5.
A person has been receiving ibuprofen for
many years to relieve the pain of osteoarthritis.
Assessment of the person should include:
a.
an electrocardiogram.
b.
FBC with differential.
c.
respiratory auscultation.
d.
renal evaluation.
